Abbott Receives FDA Approval for IOS-Compatible App Allowing People with Movement Disorders to Personalize Therapy Via Their Mobile Device

ABBOTT PARK, Ill., July 23, 2020 /PRNewswire/ — Abbott (NYSE: ABT) today announced it has received approval from the U.S. Food and Drug Administration (FDA) for the use of the company’s Patient Controller app on compatible personal Apple‡ smartphone devices.